AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2007
Mar 1, 2007
30339_dirs_2007-03-01_c2cd8ca6-7479-4bee-8cee-5503ef343f7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-27
Reporting Person: Paproski John E (Vice President - Innovations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-02-27 | Common Stock | A | 2245 | $44.9700 | Acquired | 16557.7590 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-02-27 | Stock Option (Right to Buy) | $44.9700 | A | 8780 | Acquired | 2018-02-27 | Common Stock (8780.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5661.1837 | Indirect |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period III.
F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27